acarbose vs semaglutide
Side-by-side comparison of acarbose and semaglutide Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Precose
Ozempic, Wegovy, Rybelsus
Acarbose is a medicine that helps lower blood sugar levels in people with type 2 diabetes. It works best when used with diet and exercise.
Ozempic is a medicine that helps lower blood sugar in adults with type 2 diabetes. It can also lower the risk of heart problems in adults with both type 2 diabetes and heart disease.
Acarbose is used to help control blood sugar in adults with type 2 diabetes. You should use it along with a healthy diet and regular exercise. This medicine helps to keep your blood sugar from getting too high after you eat.
Ozempic is used to improve blood sugar control in adults with type 2 diabetes, along with diet and exercise. It can also reduce the risk of major heart problems like heart attack, stroke, or death in adults who have both type 2 diabetes and heart disease. Ozempic has not been studied in patients with a history of pancreatitis, so other diabetes medicines may be better for you.
Acarbose slows down the digestion of carbohydrates (sugars and starches) in your body. It does this by blocking certain enzymes in your small intestine that break down carbs. This helps to prevent a sharp rise in blood sugar after meals.
Ozempic is a GLP-1 receptor agonist. It works by helping your body release insulin when your blood sugar is high. It also slows down how quickly food leaves your stomach.
- • Gas
- • Diarrhea
- • Abdominal pain
- • Nausea
- • Vomiting
- • Diarrhea
- • Abdominal pain
- • Constipation
- Low blood sugar 269
- Feeling sick to your stomach 203
- High blood sugar 200
- Feeling lightheaded 160
- Loose, watery stools 147
- Feeling sick to your stomach 10,666
- Throwing up 6,913
- Using the medicine for a purpose it's not approved for 6,532
- Loose, watery stools 6,093
- Not feeling hungry 4,428
You should not take acarbose if you have diabetic ketoacidosis or cirrhosis. Also, do not take it if you have inflammatory bowel disease, colon ulcers, or any bowel obstruction. This medicine can cause liver problems in some people. Tell your doctor right away if you develop symptoms like yellowing of the skin or eyes.
Ozempic may cause thyroid C-cell tumors. Animal studies showed that semaglutide, the active ingredient in Ozempic, caused thyroid tumors in rodents. It is not known if Ozempic causes thyroid tumors in humans. You should not take Ozempic if you or your family have a history of medullary thyroid carcinoma (MTC) or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Tell your doctor if you notice a lump in your neck, have trouble swallowing, have trouble breathing, or have a hoarse voice that won't go away.
Talk to your doctor if you are pregnant or plan to become pregnant. It is not known if acarbose will harm your unborn baby. Talk to your doctor if you are breastfeeding or plan to breastfeed. It is not known if acarbose passes into breast milk.
There is limited information about the safety of Ozempic during pregnancy. Ozempic may pose a risk to your unborn baby. Talk to your doctor if you are pregnant, plan to become pregnant, or are breastfeeding.
Also Compare — Nearby Drugs
Compare acarbose with
Compare semaglutide with
How to Read This acarbose vs semaglutide Comparison
acarbose is classified in the Alpha-Glucosidase Inhibitor drug class, while semaglutide sits within the GLP-1 Receptor Agonist class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, acarbose has 979 submissions while semaglutide has 34,632. Those figures reflect cumulative reporting volume — not per-patient risk — so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between acarbose and semaglutide — always consult your physician or pharmacist first.
Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.